Filter results
11/04/2019
ROVI will market Teva's medicine Tetridar® for the treatment of osteoporosis in adults in Spain
19/03/2019
Advanced Final Results from the Pivotal Study of its Once-monthly Injectable Antipsychotic show that Primary and Key Secondary Efficacy Endpoints Were Achieved with Both Doses Tested for the Treatment of Patients with Acute Exacerbation of Schizophrenia
26/02/2019
Download our press release published on 26 February to find out the financial results for the full year 2018.
26/02/2019
Operating income, growth figures, profitability and how our products have behaved.